Evidence map›Paper›PMID 35849309›Full record

ArticleLa Radiologia medica2022

Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.

Francesco Pasqualetti, Michela Gabelloni, Alessandra Gonnelli, Lorenzo Faggioni, Martina Cantarella, Sabrina Montrone, Giovanni Gadducci, Noemi Giannini, Nicola Montemurro, Roberto Mattioni and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Two-arm study of sarcopenia in geriatric patients with high-grade glial tumors: temporal muscle thickness and prognostic nutritional index.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  4. Review
  5. Article
  6. Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors.Diagnostics (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Review
  9. Radiomics in Lung Metastases: A Systematic Review.Journal of personalized medicine · 2023
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Francesco PasqualettiOncology Department, Oxford University, Roosevelt Drive, Oxford, OX3 7DQ, UK. francesco.pasqualetti@oncology.ox.ac.uk.ORCID http://orcid.org/0000-0002-0788-1205
Michela GabelloniRadiology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Alessandra GonnelliRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Lorenzo FaggioniRadiology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Martina CantarellaRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Sabrina MontroneRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Giovanni GadducciRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Noemi GianniniRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Nicola MontemurroNeurosurgery Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Roberto MattioniRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Paolo PerriniNeurosurgery Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Riccardo MorgantiStatistic Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Mirco CosottiniNeuroradiology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Emanuele NeriRadiology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.
Fabiola PaiarRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Via Roma 67, 56123, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is an unmet need for new biomarkers able to predict both the outcomes of up-front therapy and the compliance of elderly patients diagnosed with glioblastoma. For this purpose, temporal muscle thickness is a promising tool to be investigated.

methodsData from 52 glioblastoma patients older than 65 years, treated with post-operative radio or radio-chemotherapy and referred to Pisa University Hospital, were retrieved. The thickness of temporal muscle (TMT) was divided into quartiles and correlated with overall survival (Our primary endpoint). Survival curves were calculated using Kaplan-Meier method, and log-rank test was used to evaluate the differences between curves.

resultsPatients in the lower quartile of TMT, with TMT thinner than 7 mm, have survived longer; both univariate and multivariate analyses showed a statistically significant correlation between TMT and overall survival (P = 0.012 and P = 0.003, respectively).

conclusionFuture prospective and more extensive studies focused on elderly glioblastoma patients are needed to confirm the role of TMT as prognostic value on OS and to help explaining this association.

Indexed as

Brain NeoplasmsGlioblastomaAgedChemoradiotherapyHumansPrognosisRetrospective StudiesTemporal MuscleElderly patientsElderly patients with glioblastomaGeriatric oncology sarcopeniaGlioblastomaGlioblastoma biomarkersRadiotherapyTemporalis thickness

Identifiers

PMID35849309

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.